Saarbrücken, 25 April 2022. Saarbrücken-based pharmaceutical company URSAPHARM is extending its POSIFORLID® product portfolio with eyelid hygiene wipes for treating …Find out more
News from the company
URSAPHARM extends POSIFORLID® portfolio with eyelid hygiene wipes
New Partnership Expands Scope’s Dry Eye Portfolio with the launch of the OPTASE® HYLO® range of dry eye products in the USA from June 2021.
New York, N.Y. – May 17, 2021 – Scope Eyecare and URSAPHARM Arzneimittel GmbH have been partners collaborating in the European dry eye sector for nearly 12 years. An exciting new partnership for the US paves the way for the next phase of this partnership with the creation and launch of a co-branded range of […]Find out more
HYLO COMOD® is the star product of HYLO® product range. It was launched in Germany in 1999 and since years HYLO COMOD® is the market leading eye care product in Germany and Europe. For more than 20 years, we insist on production in German and supply to the World, and now sell well in 74 […]Find out more
URSAPHARM becomes EYE CARE partner of FC Bayern München
On the occasion of the press conference in Munich on 16-08-2017 the URSAPHARM company proclaimed the new “golden” partnership with the FC Bayern München. Besides the managing director and shareholder Dominik Holzer and the executive director of sales and marketing Christian Krensel the managing directors of the FC Bayern München, M. Karl-Heinz Rummenigge and M. Andreas Jung answered to the questions of the numerous representatives of the media.Find out more
Exclusive world premiere of the URSAPHARM Virtual Reality Experience on the occasion of the AAD 2017
On 13-03-2017, at the beginning of this year’s ophthalmological specialist conference AAD in Düsseldorf, the URSAPHARM company presented exclusively the “Eye-Explorer Virtual Reality” App for the first time.Find out more
Read the latest product updates, information and company news from URSAPHARM Arzneimittel GmbH or find out about the most recent research findings. We will always keep you up to date on innovations and developments in the company.